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Summary
Obesity and the obesity-associated metabolic dysfunctions are a major health and economic
burden. Adipocyte-secreted proteins play an important role in obesity-associated disorders.
Therefore it is essential to study the secreted factors of human (pre)adipocytes, not only to
understand the underlying mechanisms of obesity-induced metabolic complications, but also
to gain more insight in the regulation of weight gain, weight loss, weight re-gain and weight
maintenance. This may aid the development of successful treatment strategies for obesity
and its related complications.
In vivo studies are usually confined to plasma and other body fluids and as such the results
demonstrate the effect of an intervention but not the underlying molecular mechanisms. That
is why in vitro studies of human (pre)adipocytes and adipose tissue are necessary. Technical
issues of proteomics technologies, including false positive identification, limited throughput,
low sensitivity and quantification still do not allow identifying the complete (pre)adipocyte
secretome. However, improved MS approaches developed during the last 10 years have
helped to increase the understanding of the adipose tissue/adipocyte proteome and its
regulation, including the adipocyte-secreted proteins. Nevertheless, much is still unknown
about the molecular mechanisms responsible for the development of obesity and its
metabolic complications, as well as strategies to improve the obesity-induced metabolic
phenotype. This thesis describes in vitro studies with human SGBS (pre)adipocytes which
were investigated regarding the regulation of (pre)adipocyte-specific secreted proteins in the
context of triglyceride (TG) accumulation/excess, adipocyte differentiation and TG
reduction/increased lipolysis.
Chapter 2 evaluates relevant proteomic technologies in the field of adipocyte biology. In this
context new findings, new molecular aspects of adipocyte biology and the discovery of novel
adipokines within the adipocyte research field were presented and discussed. They have led
to the conclusion that a combination of analysis techniques is essential to cover the
identification of the total (pre)adipocyte proteome as well as changes therein.
Secretion differences of SGBS (pre)adipocytes during adipogenesis are described in
chapter 3. Secretome profiling was performed on both cell types which led to the
identification of 6 novel human adipocyte-secreted proteins. In addition, this study revealed
20 proteins that had not been detected before in human adipose material. In addition, 23
proteins that were previously detected in visceral adipose tissue were found to be secreted
by SGBS-cells of subcutaneous origin. Furthermore, this secretome study confirmed SGBS
cells as an ideal human (pre)adipocyte cell strain for adipocyte-related proteomics studies.
Tissue factor (TF) is involved in blood coagulation. Consequently, altered expression of TF
during adipose tissue expansion might contribute to the development of obesity-induced
thrombosis. As such, we investigated possible TF expression by SGBS (pre)adipocytes,
which is reported in chapter 4. On both cell types and in the medium TF-mediated factor Xa
and thrombin activation was observed. Our results indicate that human (pre)adipocytes
express functional TF, which may have implications for obesity-induced thrombosis but also
for extravascular fibrosis and angiogenesis.
Increased TG accumulation leads to increased adipose tissue mass, which might result in
hypoxic conditions. Hypoxic areas have been observed in WAT of obese persons. This may
lead to WAT dysregulation and development of obesity-associated metabolic dysregulation.
In chapter 5 we describe that CoCl2-induced hypoxic secretome changes of (pre)adipocytes
are mostly associated with protein down-regulation and a dysregulation of the extracellular
matrix. This confirmed the hypothesis that hypoxia induces detrimental effects within
enlarged adipose tissue of obese subjects. Such dysregulation was reflected by an up-
regulation of collagens in adipocytes which indicated a cell survival process. In preadipocytes
collagens were down-regulated which might be indicative for a disturbed differentiation
process. In addition, we identified 9 novel (pre)adipocyte secreted proteins of which 6 were
regulated by hypoxia.
Treatment strategies for obesity and obesity-induced complications are essential to cope with
their associated medical problems. As such, investigation of promising drugs or food
supplements is a key feature of obesity research. Since resveratrol (RSV) is known to mimic
beneficial health effects of calorie restriction more and more research is performed to
understand its biological mechanism. The study in chapter 6 reveals an RSV-mediated
increase of intracellular lipolysis, which resulted in a beneficial change of the adipocyte
secretion profile. As such, ECM proteins were down-regulated while process-related proteins
were mostly up-regulated. In addition, the secretion of proteins that are protective against
cellular stress and of proteins involved in the regulation of apoptosis were up-regulated.
Furthermore, RSV induced an up-regulation of adiponectin and ApoE and a down-regulation
of PAI-1 and PEDF secretion. This indicated a positive impact on the adipocyte-secretome
towards an improved obesity-associated inflammatory phenotype and metabolic dysfunction.
In addition, 2 novel RSV-regulated adipocyte-secreted proteins were identified.
Another treatment strategy of obesity is a calorie restricted diet. An in vitro effect of CR on
the human adipocyte secretion profile had not been investigated before. As such, chapter 7
describes the identification of 6 novel adipocyte-secreted proteins that are regulated by CR.
In addition, it was shown that CR-induced adipocyte TG reduction led to a positively affected
adipokine secretion pattern indicative for an improved inflammatory phenotype and an
improved obesity-associated metabolic dysfunction including insulin resistance and glucose
intolerance.
To distinguish between advantages and disadvantages of an RSV versus a calorie restricted
intervention a comparison of the secretion profile of both obesity treatment strategies was
also performed and described in chapter 7. CR and RSV differently affected the SGBS
adipocyte secretion profile in which both interventions show an improvement of the obesity-
associated inflammatory phenotype and the obesity-associated metabolic disorders while CR
seems less forceful but appears to reach its positive effects with minor cellular stress.
All these studies were related to the investigation of the human (pre)adipocyte secretome. In
chapter 8 the results have been critically discussed in the context of the advantages and
disadvantages of the used human cell model and the applied proteomics techniques. It is
argued that technical improvement of analysis methods together with the acceptance of
individual biological responses might increase the understanding of the endocrine function of
the adipose tissue. This may aid the further development of improved obesity treatment
strategies.
